My Account


Notice: Undefined index: paysid in /homez.38/delphige/www/modeles/standard/commons/identificationBox.php on line 48

Change your country

Login - Register

Cart

Your Shopping Cart is empty.

Order on-line

Promotions

News

RSS

Delphi Genetics at BioForum Shanghai 2012
Delphi Genetics will be present at the BioForum Shanghai 2012 (China) from

read more

Delphi Genetics at the World Vaccine Congress 2012
Delphi Genetics is Gold Sponsor at the World Vaccine Congress 2012 in Washington

read more

Delphi Genetics at BioSpring 2012
  Delphi Genetics will be present at the BioSpring Partnering 2012 ta

read more

The new DNAVAC research project targets the removal of antibiotics in veterinary DNA-vaccines
The new DNAVAC research project targets the removal of antibiotics in veterinary

read more

Search

New Products

You are here : About us > Press releases

You may select a press releases to view :
 
< previous next >

Delphi Genetics participation to the AMERE study granted by the European Space Agency (ESA)

23 Jan 2012

 

Nivelles, Belgium, 23of January 2012 – Lambda-X, Delphi Genetics, The department of molecular biotechnology, bio-imaging and cytometry from the University of Ghent and Canberra have the pleasure to announce they joined forces for the AMERE study granted by the European Space Agency (ESA).
 

 

« AMERE - Autonomous Microscope for Examination of Radiation Effects »
AMERE is an autonomous microscope currently under development aiming at the study of the effects of high-energy radiation on human cells. The principle of the experiment is to bring living cells on the moon and expose them to cosmic radiation during a long period. There, the cells will be irradiated and will consequently trigger self-repair mechanism that will be investigated using a high-resolution microscope. In parallel, radiation will be monitored via a dedicated particle detector. The study of cell repair mechanism has a great impact in life science domain, mostly regarding future deep-space travel and human-radiation interactions. This study is carried out under a programme of and funded by the European Space Agency. Lambda-X SA, specialized in the development and manufacturing of systems for vision and optical metrology for aerospace, industrial and ophthalmological applications, is the study leader.
The subcontractors are:
1) Delphi Genetics SA who develops more effective products and technologies for genetic engineering and protein expression,
2) The department of molecular biotechnology, bio-imaging and cytometry from the University of Ghent and
3) Canberra, a world leader in measurement solution and expertise for the radiobiological emergency response and environment monitoring.
 
About Lambda-X
Lambda-X S.A. designs, develops, manufactures and markets vision systems and optical metrology devices for Aerospace, Industrial and Ophthalmological applications.
Since the start of its activities in 1996, Lambda-X has invented, developed and assembled more than 25 high-tech optical instruments that have flown in satellites, sounding rockets and even the International Space Station. Lambda-X provides optical engineering services to industries. Our constant concern is the improvement or the development of solutions tailored on the client specifications. Last but not least, Lambda-X has developed a proprietary range of instruments called NIMO, capable of quantifying the optical properties of ophthalmic corrective elements such as glasses, contact and intraocular lenses, as well as reflective surfaces such as mirrors. Those robust yet fast instruments are typically used in quality control and production environments worldwide.
About Delphi Genetics
Founded at the end of 2001, Delphi Geneticsdevelops more effective products and technologies for genetic engineering and for protein expression in bacteria by using its unique expertise in the field of plasmid stabilisation systems. Delphi Genetics’ patented StabyExpress technology (licensed to Sanofi Pasteur and GSK) increases the recombinant protein production output without the use of antibiotics, which is the traditional approach.
 
About the Bio-imaging and Cytometry Unit, department of Molecular Biotechnology, University of Ghent
The Bio-imaging and Cytometry Unit pioneered with confocal microscopy in Europe over two decades ago. Since then, a strong expertise has grown in confocal and other light microscopical techniques dedicated to a broad range of biological applications. This tradition has been crowned with the establishment of a new bio-imaging facility at the Faculty of Bioscience Engineering. The group focuses on generating a systems level understanding of premature and normal ageing, by means of minimally invasive imaging technology and high throughput automated microscopy. Our interdisciplinary expertise in biophotonics has been called upon in several space-related projects. We have participated in three different space missions (Foton M3, Odissea, STS-107) with biological experiments in the form of compact lab-on-chip devices. In addition we have participated in two ground-based studies for the European Space Agency lead by Lambda-X (DIRSOL: Directional Solidification facility, AMME: Advanced microscopy methods).
 
About Canberra
CANBERRA is a world leader in providing measurement solutions and expertise for Radiological Emergency Response and Environmental Monitoring. CANBERRA, an AREVA company, is the worldwide leader in nuclear measurements. With over 40 years of experience in this field, we bring solutions to our customers, not just proudtcs or services.
The key to our success lies in our ability to identify the right customers and understand their needs, in order to bring them value-adding and innovative solutions. In addition, we strive to meet all of the commitments that we make to our customers.
 
Disclaimer: The view expressed herein can in no way be taken to reflect the official opinion of the European Space Agency.
 
< previous next >